These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 12761811)

  • 21. A strategy to reduce biliary clearance in early drug discovery.
    Rioux N; Bellavance E; Poirier H; Dupuis M; Garneau M; Ribadeneira MD; Duan J
    J Pharmacol Toxicol Methods; 2013; 68(3):346-8. PubMed ID: 23518065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans.
    Li C; Liu T; Broske L; Brisson JM; Uss AS; Njoroge FG; Morrison RA; Cheng KC
    Biochem Pharmacol; 2008 Dec; 76(12):1757-64. PubMed ID: 18835257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers.
    Tavelin S; Taipalensuu J; Söderberg L; Morrison R; Chong S; Artursson P
    Pharm Res; 2003 Mar; 20(3):397-405. PubMed ID: 12669959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
    Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
    Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
    Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
    Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
    Chanoine F; Grenot C; Heidmann P; Junien JL
    Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
    Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
    Yuan Y; Zhang H; Sun F; Sun S; Zhu Z; Chai Y
    J Ethnopharmacol; 2015 Apr; 163():31-8. PubMed ID: 25596352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.
    Lennernäs H
    Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption barriers in the rat intestinal mucosa: 1. Application of an in situ perfusion model to simultaneously assess drug permeation and metabolism.
    Mudra DR; Borchardt RT
    J Pharm Sci; 2010 Feb; 99(2):982-98. PubMed ID: 19746412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for absorption screening in drug discovery and development.
    Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
    Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose dependency in the oral bioavailability of an organic cation model, tributylmethyl ammonium (TBuMA), in rats: association with the saturation of efflux by the P-gp system on the apical membrane of the intestinal epithelium.
    Kim MK; Han L; Choi MK; Han YH; Kim DD; Chung SJ; Shim CK
    J Pharm Sci; 2005 Dec; 94(12):2644-55. PubMed ID: 16258993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
    Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
    Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.